Diagnostic and Laboratory Testing in Psychiatry |
From inside the book
Results 1-5 of 59
Page 4
... M.D. , and H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 . Platelet Serotonin 2.2 . Platelet Monoamine Oxidase 3. Other Potential Trait Markers ... 3.1 . Cerebrospinal Fluid Metabolites 3.2 . Plasma ...
... M.D. , and H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 . Platelet Serotonin 2.2 . Platelet Monoamine Oxidase 3. Other Potential Trait Markers ... 3.1 . Cerebrospinal Fluid Metabolites 3.2 . Plasma ...
Page 5
121 121 122 123 124 125 126 11. Therapeutic Drug Level Monitoring in Psychiatry ... 131 Sheldon H. Preskorn , M.D. , Mark S. Gold , M.D. , and Irl Extein , M.D. 1. The Significance of Drug Plasma Concentrations 131 ...
121 121 122 123 124 125 126 11. Therapeutic Drug Level Monitoring in Psychiatry ... 131 Sheldon H. Preskorn , M.D. , Mark S. Gold , M.D. , and Irl Extein , M.D. 1. The Significance of Drug Plasma Concentrations 131 ...
Page 21
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 23
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 26
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
I | 9 |
III | 9 |
IV | 9 |
V | 9 |
VI | 9 |
VII | 9 |
VIII | 9 |
IX | 10 |
CXXVIII | 124 |
CXXIX | 129 |
CXXXI | 130 |
CXXXII | 131 |
CXXXIV | 132 |
CXXXV | 134 |
CXXXVI | 135 |
CXXXVII | 136 |
X | 11 |
XIII | 12 |
XVI | 13 |
XIX | 14 |
XXII | 15 |
XXVII | 16 |
XXIX | 17 |
XXX | 18 |
XXXI | 25 |
XXXIII | 26 |
XXXIV | 29 |
XXXVII | 30 |
XXXVIII | 36 |
XXXIX | 37 |
XL | 38 |
XLII | 39 |
XLIII | 40 |
XLV | 41 |
XLVI | 42 |
XLVII | 43 |
XLVIII | 45 |
L | 46 |
LI | 47 |
LIV | 48 |
LVI | 49 |
LVII | 50 |
LVIII | 51 |
LXI | 53 |
LXIII | 54 |
LXIV | 57 |
LXV | 58 |
LXVI | 59 |
LXVII | 60 |
LXVIII | 61 |
LXIX | 62 |
LXXI | 63 |
LXXIII | 64 |
LXXIV | 66 |
LXXVI | 68 |
LXXVIII | 69 |
LXXX | 70 |
LXXXII | 71 |
LXXXIII | 72 |
LXXXIV | 75 |
LXXXVII | 77 |
LXXXVIII | 78 |
LXXXIX | 79 |
XC | 80 |
XCII | 81 |
XCIV | 82 |
XCV | 85 |
XCVI | 86 |
XCVII | 87 |
XCVIII | 88 |
C | 90 |
CII | 91 |
CIII | 92 |
CIV | 93 |
CV | 97 |
CVI | 98 |
CVII | 99 |
CVIII | 101 |
CIX | 103 |
CX | 104 |
CXI | 105 |
CXIV | 106 |
CXV | 107 |
CXVI | 108 |
CXVII | 109 |
CXVIII | 110 |
CXX | 111 |
CXXI | 113 |
CXXII | 115 |
CXXIII | 116 |
CXXIV | 120 |
CXXV | 121 |
CXXVI | 122 |
CXXVII | 123 |
CXXXIX | 137 |
CXL | 138 |
CXLI | 139 |
CXLII | 140 |
CXLIII | 141 |
CXLIV | 142 |
CXLV | 143 |
CXLVI | 144 |
CXLVII | 145 |
CXLVIII | 147 |
CXLIX | 148 |
CLI | 149 |
CLII | 150 |
CLIII | 153 |
CLIV | 154 |
CLV | 155 |
CLVII | 156 |
CLVIII | 157 |
CLIX | 159 |
CLX | 160 |
CLXI | 161 |
CLXII | 162 |
CLXIII | 164 |
CLXIV | 167 |
CLXV | 169 |
CLXVI | 171 |
CLXVII | 172 |
CLXVIII | 174 |
CLXIX | 177 |
CLXX | 179 |
CLXXI | 180 |
CLXXII | 183 |
CLXXIII | 185 |
CLXXV | 186 |
CLXXVI | 189 |
CLXXVII | 193 |
CLXXIX | 194 |
CLXXX | 195 |
CLXXXI | 196 |
CLXXXIII | 197 |
CLXXXIV | 198 |
CLXXXVI | 199 |
CLXXXVIII | 200 |
CLXXXIX | 201 |
CXCI | 202 |
CXCII | 203 |
CXCIV | 204 |
CXCVII | 205 |
CXCVIII | 208 |
CC | 209 |
CCI | 213 |
CCII | 218 |
CCIII | 219 |
CCIV | 224 |
CCV | 230 |
233 | |
CCVII | 235 |
CCVIII | 237 |
CCIX | 238 |
CCX | 239 |
CCXI | 240 |
CCXII | 242 |
CCXIII | 243 |
247 | |
CCXV | 249 |
CCXVI | 250 |
CCXVII | 251 |
CCXVIII | 252 |
CCXIX | 253 |
CCXX | 254 |
259 | |
CCXXII | 261 |
CCXXIV | 263 |
CCXXV | 264 |
CCXXVI | 266 |
CCXXVII | 267 |
269 | |
Common terms and phrases
abnormal abuse activity addition affective disorders alcohol anorexia antidepressant anxiety Arch Gen Psychiatry assessment associated behavior bipolar blood body brain cause central changes chronic Clin clinical complex concentration correlate cortisol criteria decreased deficiency dementia depressed patients detection determined dexamethasone diagnosis differential disease dose drug endogenous et al evaluation examination factors findings function glucose Gold growth half-life hormone Hospital hypothyroidism imaging important improve increased indicated laboratory lead levels lithium major depression mania measure mental metabolites MHPG mood neurological normal occur organic panic patterns physical plasma platelet positive possible present produce psychiatric psychosis psychotic recent relationship release reported response sample scales scan schizophrenia screen secretion sensitive serotonin serum severe significant signs specific stimulation studies substance suggested suppression symptoms syndrome Table thyroid tion treated treatment urine usually withdrawal York